|

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

RECRUITINGSponsored by Istituto Nazionale di Ricovero e Cura per Anziani
Actively Recruiting
SponsorIstituto Nazionale di Ricovero e Cura per Anziani
Started2025-04-09
Est. completion2026-06-30
Eligibility
Age65 Years+
Healthy vol.Accepted

Summary

The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.

Eligibility

Age: 65 Years+Healthy volunteers accepted
GROUP 1: Patients hospitalized for acute neurological disorders

Inclusion criteria:

* Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis

Exclusion criteria:

* no informed consent

GROUP 2: Patients hospitalized for non-neurological diseases with dementia

Inclusion criteria:

* inpatients with diagnosis of major neurocognitive disorder according to DSM-5 criteria (2013)

Exclusion criteria:

* Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
* no informed consent

GROUP 3: Patients hospitalized for non-neurological diseases without dementia

Inclusion criteria:

* inpatients with non-neurological diseases

Exclusion criteria:

* inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
* diagnosis of dementia
* no informed consent

Conditions3

Alzheimer DiseaseAlzheimer's DiseaseOld Age; Dementia

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.